← National Community Pharmacists Association
FDANonrulemakingFDA-2017-D-1956

Identifying Trading Partners Under the Drug Supply Chain Security Act

RIN
—
Last modified
Sep 7, 2022
Comment window
closed 1421d ago
National Community Pharmacists Association filings
2

Activity

National Community Pharmacists Association filed 2 comments on this docket between Nov 1, 2017 and Sep 7, 2022. 9 other organizations filed here. The comment window closed 1421d ago.

What National Community Pharmacists Association filed (2)

Sep 7, 2022· Comment from National Community Pharmacists Association· FDA-2017-D-1956-0038

NCPA represents America's community pharmacists, including 19,400 independent community pharmacies. Almost half of all community pharmacies provide long-term care services and play a critical role in ensuring patients have immediate access to medications in both community and long-term care (LTC) settings. Together, our members represent a $67 billion healthcare marketplace, employ 215,000 individuals, and provide an expanding set of healthcare services to millions of patients every day. Our members are small business owners who are among America's most accessible healthcare providers. Attached please find our comments. NCPA thanks FDA for the opportunity to provide feedback, and we stand ready to work with FDA to offer possible solutions and ideas. Should you have any questions or concerns, please feel free to contact me at steve.postal@ncpa.org or (703) 600-1178.

View on regulations.gov →
Nov 1, 2017· Comment from American Pharmacists Association (APhA) and the National Community Pharmacists Association (NCPA)· FDA-2017-D-1956-0015

Please see APhA and NCPA's joint comments attached.

View on regulations.gov →

Abstract

No abstract recorded.

View on regulations.gov →

Co-filers (9)

See everyone who commented →